Abbott Jun 2, 2026 ASCO26: Abbott demonstrates MRD test benefit in TNBC recurrence - Medical Device Network
Abbott Jun 1, 2026 Advances in Molecular Residual Disease Detection and Risk Stratification: Insights from Abbott Cancer Diagnostics - Onco'Zine
Abbott May 28, 2026 Abbott obtains CE mark for duo of glucose-ketone monitors - Medical Device Network
Abbott May 27, 2026 How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026 - Yahoo! Finance Canada
Abbott May 26, 2026 Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 - PR Newswire
Abbott May 23, 2026 Abbott Deepens Digital Health Push With New Cardiovascular Diagnostics And Wearables - simplywall.st
Abbott May 21, 2026 Abbott Laboratories stock (US0028241000): diabetes business and latest earnings in focus - AD HOC NEWS
Abbott May 19, 2026 Abbott Laboratories stock (US0028241000): steady momentum after latest earnings and diabetes tech pu - AD HOC NEWS
Abbott May 13, 2026 Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold? - TradingView
Abbott May 11, 2026 Lateral Flow Assay Component Market Is Going to Boom | Abbott Laboratories, BD - openPR.com
Abbott May 8, 2026 Abbott's Medical Device Strategy Supports Long-Term Growth Outlook - The Globe and Mail
Abbott May 8, 2026 Abbott's Medical Device Strategy Supports Long-Term Growth Outlook - Yahoo Finance
Abbott May 8, 2026 Abbott's Medical Device Strategy Supports Long-Term Growth Outlook - Yahoo Finance UK
Abbott May 8, 2026 Abbott's Medical Device Strategy Supports Long-Term Growth Outlook - Yahoo Finance Singapore
Abbott Apr 28, 2026 Point of Care Diagnostics Market | Abbott Laboratories, BD, Danaher Corp, Nova Biomedical Corporation etc. - openPR.com
Abbott Apr 27, 2026 HRS 2026: Medtronic, Boston Scientific and Abbott debut key PFA data - Medical Device Network